| Structure | Chemical Name | CAS | MF |
|
3-IODOINDOLE-2-CARBOXYLIC ACID
|
167631-58-5
|
C9H6INO2
|
|
5-FLUORO-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER
|
167631-84-7
|
C10H8FNO2
|
|
1H,1H-PERFLUORO(2,5,8,11,14,17-HEXAMETHYL-3,6,9,12,15,18-HEXAOXAHENEICOSAN-1-OL)
|
167631-99-4
|
C21H3F41O7
|
|
1-Amine-1-carba-closo-dodecaborane(11)
|
167632-33-9
|
CH2B11N
|
|
1-[(4-Ethoxyphenyl)ethynyl]-4-(4-propylcyclohexyl)benzene
|
167633-81-0
|
C25H30O
|
|
Ethyl-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methyl-2,4-pentadienoate
|
167637-41-4
|
C18H24O3
|
|
5-(4-Methoxy-2,3,6-trimethylphenyl)-3-methyl-2,4-pentadien-1-ol
|
167637-42-5
|
C16H22O2
|
|
6-Me-Indenestrol A
|
167638-43-9
|
C19H20O2
|
|
4-(1-ethyl-5-methoxy-3-methyl-1H-inden-2-yl)phenol
|
167638-45-1
|
C19H20O2
|
|
4,5-BENZO-1'-ETHYL-3,3,3',3'-TETRAMETHYL-1-(4-SULFOBUTYL)INDODICARBOCYANIN-5'-ACETIC ACID N-SUCCINIMIDYL ESTER
|
167638-53-1
|
C41H45N3O7S
|
|
Succinimidyl-Hynic
|
167639-20-5
|
C10H10N4O4
|
|
3-(S)-N-CBZ-TETRAHYDROFURAN-3-YL-AMINE
|
167640-78-0
|
C12H15NO3
|
|
2-(4-Hydroxy-1-piperidinyl)isonicotinic acid
|
167641-00-1
|
C11H14N2O3
|
|
3-(1,3-DIOXAN-2-YL)PROPIOPHENONE
|
167644-49-7
|
C13H16O3
|
|
3-ACETOXY-2-METHYLBENZOYL CHLORIDE
|
167678-46-8
|
C10H9ClO3
|
|
GASA protein
|
167679-73-4
|
|
|
3-(2,6-Difluorophenyl)propionic Acid
|
167683-63-8
|
C9H8F2O2
|
|
5-AMINO-4-BROMO-3-METHYLPYRAZOLE HYDROBROMIDE
|
167683-86-5
|
C4H7Br2N3
|
|
2-FLUORO-4-METHOXYPHENOL
|
167683-93-4
|
C7H7FO2
|
|
Benzene, 1-ethoxy-4-fluoro-2-(methoxymethoxy)- (9CI)
|
167683-96-7
|
C10H13FO3
|
|
2-Thiazolamine, 4-ethyl-N-methyl-
|
167684-00-6
|
C6H10N2S
|
|
6-Ethoxy-2,3-difluorobenzaldehyde
|
167684-02-8
|
C9H8F2O2
|
|
Cyanamide, [2-(2-pyridinyl)ethyl]- (9CI)
|
167684-04-0
|
C8H9N3
|
|
3,3'-Diaminobenzidine tetrahydrochloride dihydrate
|
167684-17-5
|
C12H17ClN4O
|
|
3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid
|
167684-63-1
|
C33H43NO5S
|
|
2-Azetidinecarboxylicacid,3-amino-4-oxo-1-sulfo-,(2R-trans)-(9CI)
|
167685-65-6
|
C4H6N2O6S
|
|
FMOC-TRANEXAMIC ACID
|
167690-53-1
|
C23H25NO4
|
|
1,4-Pentanedione, 1-cyclopropyl- (9CI)
|
167692-57-1
|
C8H12O2
|
|
2-Cyclohexylethylboronic acid
|
167692-95-7
|
C14H27BO2
|
|
DOYLE DIRHODIUM CATALYST-RH2(4S-MEOX)4
|
167693-36-9
|
C20H28N4O16Rh2
|
|
2,3-Aziridinedicarboxylicacid,monoethylester,(2S,3S)-(9CI)
|
167693-85-8
|
C6H9NO4
|
|
Pentanamide, 2-amino-4-methyl-N-(3-methylbutyl)-, hydrochloride (1:1), (2S)-
|
167693-86-9
|
C11H25ClN2O
|
|
10-hydroxyeicosatetraenoic acid
|
167697-52-1
|
C20H32O3
|
|
BENZYLOXYCARBONYL-L-LEUCYL-L-ARGINYLGLYCYLGLYCINE 4-METHYLCOUMARYL-7-AMIDE
|
167698-68-2
|
C34H44N8O8
|
|
Z-ARG-LEU-ARG-GLY-GLY-AMC
|
167698-69-3
|
C40H56N12O9
|
|
2-Phenyl-1-(phenylmethyl)-4-piperidinone
|
167705-56-8
|
C18H19NO
|
|
(S)-(-)-2,2'-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6'-dimethoxy-1,1'-biphenyl,min.97%
|
167709-31-1
|
C70H96O2P2
|
|
2-Thiazolamine, 5-methyl-N-propyl-
|
167710-13-6
|
C7H12N2S
|
|
4-Thiazolemethanol,4,5-dihydro-5-methylene-2-(1-methylethyl)-(9CI)
|
167710-16-9
|
C8H13NOS
|
|
1-[4-AMINO-5-CHLORO-2-(3,5-DIMETHOXYPHENYL)METHYLOXY]-3-[[1-[2-METHYLSULPHONYLAMINO]ETHYL]PIPERIDIN-4-YL]PROPAN-1-ONE HYDROCHLORIDE
|
167710-87-4
|
C26H37Cl2N3O6S
|
|
5-nitro-gamma-tocopherol
|
167711-25-3
|
C28H47NO4
|
|
|
Sulesomab
|
167747-19-5
|
|
|
|
Felvizumab
|
167747-20-8
|
|
|
|
MANGO KERNEL OIL, MANGO BUTTER, MANGO SEED OIL
|
167747-36-6
|
|
|
BENZYL-D7-AMINE
|
167750-79-0
|
C7H9N
|
|
(1R 2S 4R)-(-)-4-(1-METHYLETHYL)-2-(1-M&
|
167752-95-6
|
C18H28O
|
|
tert-Butyl N-(3-aMinobenzyl)-N-(ethyl)carbaMate
|
167756-91-4
|
C14H22N2O2
|
|
BENZYL 4-(AMINOCARBONYL)TETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE
|
167757-45-1
|
C14H18N2O3
|
|
benzyl 4-[amino(thiocarbonyl)]piperidine-1-carboxylate
|
167757-46-2
|
C14H18N2O2S
|
|
7-CHLORO-4-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER
|
167758-07-8
|
C13H12ClNO4
|
|
[4-(2-METHYLIMIDAZOL-1-YL)PHENYL]METHANOL
|
167758-58-9
|
C11H12N2O
|
|
3-(2-METHYL-1H-IMIDAZOL-1-YL)BENZONITRILE
|
167758-85-2
|
C11H9N3
|
|
(3-(2-METHYL-1H-IMIDAZOL-1-YL)PHENYL)METHANOL
|
167758-86-3
|
C11H12N2O
|
|
Benzoic acid, 2-chloro-4-fluoro-, ethyl ester
|
167758-87-4
|
C9H8ClFO2
|
|
ethyl 4-fluoro-2-methylbenzoate
|
167758-88-5
|
C10H11FO2
|
|
4',2,2-TRIMETHYLBUTYROPHENONE
|
167760-72-7
|
C13H18O
|
|
4-amino-3-trifluoromethyl-benzoic acid methyl ester
|
167760-75-0
|
C9H8F3NO2
|
|
4-CYANOPHENYLETHYLAMINE HCL
|
167762-80-3
|
C9H11ClN2
|
|
2-(4-Benzyloxy-phenyl)-2-Methyl-propionitrile
|
167762-83-6
|
C17H17NO
|
|
CIS-2-(2-BUTEN-1-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
|
167773-12-8
|
C10H19BO2
|
|
3-epidehydrotuMulosic acid
|
167775-54-4
|
C31H48O4
|
|
CAGED FLUORESCEIN MALEIMIDE*
|
167776-24-1
|
C37H26N4O12
|
|
Benzoic acid,4,4'-(21H,23H-porphine-5,15-diyl)bis-
|
167777-26-6
|
C34H22N4O4
|
|
Butanedioic acid, 2-cyano-3-methyl-, 4-ethyl 1-(2-propenyl) ester, [S-(R*,R*)]- (9CI)
|
167778-93-0
|
C11H15NO4
|
|
Butanedioic acid, 2-cyano-3-methyl-, 4-ethyl 1-(2-propenyl) ester, [R-(R*,S*)]- (9CI)
|
167778-99-6
|
C11H15NO4
|
|
N-(9-ANTHRYLMETHYL)-N-BENZOYL-N-METHYL-T
|
167781-43-3
|
C24H20N2OS
|
|
1-CYCLOPROPYL-1,2,3,4-TETRAHYDRO-ISOQUINOLINE
|
167781-50-2
|
C12H15N
|
|
|
Faralimomab
|
167816-91-3
|
|
|
2-Iodo-L-Phenylalanine
|
167817-55-2
|
C9H10INO2
|
|
LAURYL POLYGLUCOSE
|
167817-58-5
|
C18H38O7
|
|
|
proteinase inhibitor ATI
|
167821-94-5
|
|
|
3,4-Furandiamine,tetrahydro-(9CI)
|
167822-03-9
|
C4H10N2O
|
|
(4R,5S,6S,7R)-1,3-dibenzyl-5,6-dihydroxy-4,7-bis(naphthalen-2-ylmethyl )-1,3-diazepan-2-one
|
167826-61-1
|
C41H38N2O3
|
|
TERT-BUTYL 4-BROMO-3,5-DIMETHOXYBENZOATE
|
167830-43-5
|
C13H17BrO4
|
|
1-Piperidinecarboxylic acid, 4-azido-3-hydroxy-, phenylMethyl ester, (3R,4R)-rel-
|
167832-25-9
|
C13H16N4O3
|
|
trans-3-AMino-1-Cbz-4-hydroxypiperidine
|
167832-26-0
|
C13H18N2O3
|
|
trans-4-AMino-1-Cbz-3-hydroxypiperidine
|
167832-41-9
|
C13H18N2O3
|
|
2-(BENZYLOXY)-6-METHOXYBENZONITRILE
|
167832-66-8
|
C15H13NO2
|
|
4-(2-OXOPYRROLIDIN-1-YL)BENZONITRILE
|
167833-93-4
|
C11H10N2O
|
|
(S)-3-Amino-3-phenylpropanoic acid ethyl ester hydrochloride
|
167834-24-4
|
C11H16ClNO2
|
|
4-METHOXY-2-METHYLQUINOLIN-8-OL
|
167834-50-6
|
C11H11NO2
|
|
4-ETHOXY-2-METHYLQUINOLIN-8-OL
|
167834-51-7
|
C12H13NO2
|
|
2-ETHOXY-N-METHYL-1-ETHANAMINE HYDROCHLORIDE
|
167837-39-0
|
C5H14ClNO
|
|
(2E)-3-(6-Amino-3-pyridinyl)-2-propenoic acid
|
167837-43-6
|
C8H8N2O2
|
|
5-Quinoxalinol, 3-methyl-
|
167837-50-5
|
C9H8N2O
|
|
5-Quinoxalinol,2-methyl-(9CI)
|
167837-51-6
|
C9H8N2O
|
|
3-AMINO-N-(2-METHOXYETHYL)BENZAMIDE
|
167837-52-7
|
C10H14N2O2
|
|
Benzamide, 4-formyl-N-methyl- (9CI)
|
167837-57-2
|
C9H9NO2
|
|
PseudoMonic Acid F
|
167842-64-0
|
C24H40O9
|
|
TERT-BUTYL (4-AMINOPHENOXY)ACETATE
|
167843-57-4
|
C12H17NO3
|
|
Carbamic acid, (4-amino-2-butenyl)-, 1,1-dimethylethyl ester, (Z)- (9CI)
|
167845-56-9
|
C9H18N2O2
|
|
3-(2-Aminoethyl)benzoic acid methyl ester HCl
|
167846-36-8
|
C10H14ClNO2
|
|
1-BROMO-4-(4'-PROPYLCYCLOHEXYL)BENZENE
|
167858-55-1
|
C15H21Br
|
|
1-BroMo-2-fluoro-4-propylbenzene
|
167858-56-2
|
C9H10BrF
|
|
4-(4-PROPYL-CYCLOHEXYL)-PHENYL ACETYLENE
|
167858-58-4
|
C17H22
|
|
N,N-bis-4-(4,4-Diphenyl-1,3-butadienyl phenyl)phenylamine
|
167859-26-9
|
C50H39N
|
|
N,N-BIS{4-(4,4-BIS(4-METHYLPHENYL)-1,3-BUTADIENYL}PHENYL{-4-METHYLPHENYLAMINE
|
167859-28-1
|
C55H49N
|
|
N,N-BIS{4-{4,4-BIS(4-METHYLPHENYL)-1,3-BUTADIENYL}PHENYL}-4-METHOXYPHENYLAMINE
|
167859-29-2
|
C55H49NO
|
|
Phenol, 2,4-diamino-5-methoxy-
|
167859-86-1
|
C7H10N2O2
|
|
POLY(ANILINESULFONIC ACID), 5 WT. % SOLUTION IN WATER
|
167860-86-8
|
C7H9NO4S
|